Top compounds associated with response to SPATA3


Feature Type Standardized
Nominal ANOVA
mRNA PI-103 GDSC1000 pan-cancer AAC -0.0061 0.8
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.0066 0.8
mRNA Irinotecan CCLE pan-cancer AAC 0.01 0.8
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.0071 0.8
mRNA 5-FU CTRPv2 pan-cancer AAC 0.0066 0.8
mRNA isoliquiritigenin CTRPv2 pan-cancer AAC -0.013 0.8
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0062 0.8
mRNA Bicalutamide GDSC1000 pan-cancer AAC 0.0066 0.8
mRNA TW 37 GDSC1000 pan-cancer AAC -0.0065 0.8
mRNA Rapamycin gCSI pan-cancer AAC -0.01 0.8
Download CSV